Download the FREE ebook "Beating Myeloma: If I Knew Then What I Know Now" and arm yourself with the information about autologous stem cell transplantation, treatment options, and side effects that I wish I had known about when I began treatment.
I was diagnosed with multiple myeloma (MM) at the age of 34. I underwent 6 rounds of a triplet induction chemotherapy and an autologous stem cell transplant in 1995 at the age of 35. I was young, fit and could barely climb the three flights of stairs to my apartment when I came home from the hospital.
I cannot imagine what the same therapy would do to the average MM patient (67 yr.) much less a MM patient with one or two “comorbidities” aka diseases such as heart disease or diabetes.
If you are a newly diagnosed MM patient, over the age of 60, with one or two other diseases (comorbidities), the article linked and excerpted below is the single strongest arguement I can think of for undergoing as little toxicity as possible. Chemotherapy and radiation are toxic. Toxicity kills.
I’m not saying that newly diagnosed MM patients shouldn’t undergo any chemotherapy/radiation at all. While FDA approved MM regimens are often high dose, there is no reason why your oncologist can’t lower the dose or reduce the number of cycles the patient undergoes.
More importantly, there are a host of evidence-based but non-toxic theraies that MM patients can undergo. Nutrition, supplementation, moderate exercise, pre-habilitation, and others can support the newly diagnosed MMer to avoid toxicity.
Have you been diagnosed with MM? Do you have comorbidities? Scroll down the page, post a question or comment and I will reply to you ASAP.
“The majority of older adults carry 2 or more chronic conditions,” researchers said…
Data were gathered from the Veterans Affairs Healthcare System. A total of 7815 patients at least 60 years of age who were diagnosed with and treated for MM were identified. Researchers searched for 53 CMS-defined chronic and disabling conditions from claims filed by patients 3 years prior to their MM diagnosis…
Researchers identified 6 multimorbidity clusters at the time of MM diagnosis. Of the cohort,
Researchers determined that specific comorbidities had varying effects on survival rates of patients with MM:
“We found higher-impact and lower-impact multimorbidity clusters among older veterans with newly-diagnosed MM treated with chemotherapy. Unique combinations of chronic diseases may interact with MM itself to drive differences in mortality,” researchers concluded.